Itraconazol Cinfa

Itraconazole, the active ingredient in Itraconazol Cinfa, is an azole antifungal presented as an oral formulation for oral use. It treats a range of fungal infections in adults and children as prescribed by a healthcare professional. GNH USA supplies Itraconazol Cinfa as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Itraconazol Cinfa is an azole antifungal used to treat infections caused by susceptible fungi. - Dermatophytosis: eradicates skin infections caused by dermatophyte species. - Onychomycosis: clears fungal infection of the nails. - Blastomycosis: treats systemic infection caused by Blastomyces dermatitidis. - Histoplasmosis: manages disseminated disease due to Histoplasma capsulatum. - Coccidioidomycosis: combats infection by Coccidioides species. - Aspergillosis: addresses invasive disease caused by Aspergillus spp.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis after dosing. - Abdominal pain: discomfort in the upper abdomen. - Headache: transient cranial pain. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Hepatotoxicity: severe liver injury requiring monitoring. - Congestive heart failure: fluid retention and reduced cardiac function. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions. - Visual disturbances: blurred vision or photophobia. - Severe hypokalemia: low potassium levels. - Arrhythmias: irregular heart rhythms.

Before initiating therapy, consider the following precautions: - Liver function monitoring: obtain baseline tests and repeat periodically. - Drug interaction review: assess concomitant medications for CYP3A4 involvement. - Cardiac status: avoid in patients with existing heart failure. - Pregnancy assessment: use only if potential benefit outweighs risk. - Renal impairment: evaluate kidney function and adjust if necessary. - Store at ambient temperature: keep in the original packaging, protect from moisture and light.

Itraconazol Cinfa may interact with several medicines. Major Interactions (Avoid): - Rifampin: strong CYP3A4 inducer that markedly reduces itraconazole exposure. - Ketoconazole: additive hepatotoxic potential when combined. - Other CYP3A4 inducers (e.g., carbamazepine, phenytoin): decrease antifungal efficacy. Moderate Interactions (Monitor Closely): - Warfarin: itraconazole can increase INR, requiring closer coagulation monitoring. - Oral contraceptives: may reduce hormonal efficacy, consider alternative contraception.